Autologous Cellular Immunotherapy [EPC] class drugs

1 result
  • provenge

    (Sipuleucel-T)
    Dendreon Pharmaceuticals Llc
    Provenge (sipuleucel-T) is an autologous cellular immunotherapy for asymptomatic or minimally symptomatic metastatic castrate-resistant (hormone-refractory) prostate cancer.